KRONOS ADVANCED TECHNOLOGIES ANNOUNCES THE FORMATION OF A NEW MEDICAL DEVICE MANUFACTURING SUBSIDIARY, KRONOSMD INC, TO FOCUS THIS DIVISION ON MEDICAL DEVICES AND PRECISION MEDICAL COMPONENTS M – Yahoo Finance
KronosMD Inc- New KNOS Medical Device manufacturing subsidiary
Parkersburg, WV, Oct. 12, 2022 (GLOBE NEWSWIRE) — Parkersburg, WV October 11 2022 /Globenewswire/ KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), innovation-driven product development and production company that has significantly changed the way air is moved, filtered, and sterilized, announced today the formation of KronosMD Inc., a new medical manufacturing division which will focus on leveraging its expert capabilities in precision healthcare manufacturing to pursue manufacturing and technology acquisition opportunities in the Medical Devices and Precision Medical Component markets.
The KronosMD division will further continue growth and diversification in line with Kronos’ 2022 strategy. This investment, focusing on leading-edge technology in the medical electronic device industry, demonstrates Kronos’ commitment to the future of our company. With this announcement, Kronos further builds upon the electronics manufacturing diversification directives the company has launched over the past few years, including the “Transition to America” manufacturing plan focused initially on the domestic production of a highly successful line of advanced air purification/disinfection devices.
“The Kronos team has the expertise that is applicable beyond the markets in which the Company currently operates,” said Joseph Florence, Kronos’ COO and Chief Transformation Officer. “This announcement formalizes the creation of KronosMD™, a new division with a dedicated team to pursue medical device acquisitions and B2B manufacturing business opportunities”.
The medical device and new medical technologies market are growing exponentially. According to Grand View Research, The U.S. medical device manufacturers’ market size was valued at USD 176.7 billion in 2020 and is anticipated to exhibit a compound annual growth rate (CAGR) of 5.0% over the forecast period. The rising prevalence of chronic diseases and the increasing geriatric population in the country are the key market drivers. The United States remains the largest medical device market in the world.
This is an exciting new area of growth for Kronos operations. As part of our future initiatives, Kronos’ quality management and manufacturing systems have been developed to meet the required industry standards for the manufacturing of medical devices. A key strategy for KronosMD will involve the acquisition of, or the B2B manufacturing or design engagement with, innovative companies offering both (or either) currently developed products or strong R&D departments. To that point, Kronos is in current negotiations with our initial target matching this profile and offering a state-of-the-art medical imaging platform.
“Medical devices are a market where we believe we can add immediate shareholder value by leveraging our scale and manufacturing capabilities to bring innovative, high-quality solutions to the market. Kronos’ capabilities in electronics manufacturing, and our related supply chain management expertise, can be leveraged to offer medical equipment OEMs domestic contract manufacturing solutions for products designed to improve the health and well-being of today’s focused consumers. Our management’s history of successfully implementing innovative techniques and lean manufacturing principles indicates a strong future for KronosMD ™ and further serves to assure our ability to deliver value to our customers and shareholders.”- added Mr. Florence.
About Kronos Advanced Technologies, Inc.
The Company was initially founded in 2002 and funded by the U.S. military to develop electrostatic air movers. Eventually, the Company moved into the consumer air purification business. It began operations as a product development company that invented and significantly changed the way air is moved, filtered, and sterilized. Historically, Kronos has focused on developing, marketing, and selling the Company’s proprietary air movement and purification technology. Serving the Indoor Air Quality (IAQ) market, Kronos technology uses state-of-the-art high-voltage patented processes without the use of traditional porous HEPA filters. Kronos-based products move air silently, filter, sterilize, and purify the air while dramatically reducing energy consumption to half of a 60-watt light bulb. Kronos devices can be variable in shape or size and, therefore, have the potential to be scaled down for air purification in cars or scaled up in size for industrial and hazardous gas destruction. The technology is currently being implemented in multiple standalone products for businesses, homes, and vehicles of all types -to move, sterilize and filter air, including removing allergens down to 14.6 nanometers, passing through our patented technology -replacing expensive outdated passive HEPA and other filtration type systems. There are broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices. Examples of immediately addressable markets include schools, universities, healthcare facilities, operating rooms, manufacturing clean rooms, and the cabins of automobiles and commercial aircraft.
Kronos published research about the effectiveness of Kronos Patented technology on air disinfection n (e.g., microorganism destruction) by demonstrating the high efficacy of Kronos® Technology-based air purifiers in capturing and destruction of various types of microorganisms (including Corona Viruses) in different environmental settings back in 2008. Results of this research showed that Electrostatic Air Filtration and Purification systems based on Kronos technology demonstrated high capturing and destruction efficiency for different types of microorganisms, bacteria, and viruses, and can be successfully used for disinfection of air in real word environmental settings, including hospital facilities both with and without the presence of people.
BusinessWeek called Kronos air purifiers “VIRUS KILLER” in 2005.
Kronos is the first publicly traded company that accepts DOGE coin as a form of payment for its products, as well as other cryptocurrencies.
Recently, the Company filed for a provisional patent involving an innovative protective face mask with antimicrobial and anti-cellphone radiation protection features. The Company is planning to file additional patents to improve its existing technology as well as enter into new market segments but will continue to market air purifiers and other consumer products. The Company is an exclusive distributor and licensee of the latest generation of air purifiers based on the Company’s CORE technologies. The Company markets its products as Airdog® and KRONOS® brands. All Kronos products come with Kronos Promise ™ -Your Satisfaction is Guaranteed!
Company offices are located in Parkersburg, West Virginia.
Shopping portal: https://www.1800safeair.com
Follow KNOS on Twitter: https://twitter.com/kronosati
Follow KNOS on Facebook: https://www.facebook.com/kronosati
Follow KNOS on Instagram: https://www.instagram.com/kronos_ati/
Follow KNOS on Youtube: https://www.youtube.com/channel/UCdtrQDt1R26Ulh8v-S-EpJg
Follow KNOS on Reddit: https://www.reddit.com/user/Kronos_ATI
Follow KNOS on LinkedIn: https://www.linkedin.com/company/kronos-advanced-techngologies-inc
Contact us via info@kronosati.co or visit https://www.kronosati.co or https://www.1800SafeAIR.com
Disclaimer
This news release does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Kronos Advanced Technologies Inc or any other third party regardless of whether such security, product, or service is referenced in this press release. Furthermore, nothing in this press release is intended to provide tax, legal, or investment advice, and nothing in it should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction. Kronos Advanced Technologies does not represent that the securities, products, or services discussed in this press release are suitable for any particular investor. You are solely responsible for determining whether any investment, investment strategy, security, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. You should consult your business advisor, attorney, and/or tax and accounting advisor regarding your specific business, legal, or tax situation.
Social Media Disclaimer and Forward-Looking Statements.
Kronos Advanced Technologies investors and others should note that we announce material information to the public about the Company through various means, including our website (https://www.kronosati.co/investors), press releases, OTCmarkets filings, public conference calls, via our corporate Social Media accounts, listed above.
We encourage our investors and others to monitor and review the information we make public in these locations, as such information could be deemed to be material information. Please note that this list may be updated from time to time.
Certain statements contained in this press release may constitute “forward-looking statements.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the OTC Markets at OTCMarkets.com. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.
The forward-looking statements included in this press release represent the Company’s views as of the date of this press release, and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.
These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.
SOURCE: KRONOS ADVANCED TECHNOLOGIES, Inc
Phone inquiries: 1-800-SAFE-AIR (option #4)
Related Quotes
The clash of two top-10 teams will take place in Ann Arbor.
Energy inflation remains a serious concern. Protect your portfolio.
Shares of Moderna surged more than 11% on Wednesday after the biotech company [announced](https://investors.modernatx.com/news/news-details/2022/Merck-and-Moderna-Announce-Exercise-of-Option-by-Merck-for-Joint-Development-and-Commercialization-of-Investigational-Personalized-Cancer-Vaccine/default.aspx) it would develop and sell a personalized cancer vaccine with Merck. The stock was the biggest gainer on the S 500 around midday. Shares of Merck were little changed. Merck will pay Moderna $250 m
The benchmark S&P 500, which is typically viewed as the most encompassing barometer of stock market health, delivered its worst first-half return since Richard Nixon was president. The Dow Jones Industrial Average and Nasdaq Composite haven't fared any better, with both indexes mired in a bear market. A "stock split" is a mechanism that allows a publicly traded company to alter its share price and outstanding share count without affecting its market cap or operations.
The big question: Has the market hit a bottom yet? Well, according to Oppenheimer's Head of Technical Analysis Ari Wald, there are signs one is forming, the most notable of which is that the Russell 2000 index – the barometer for small-cap stocks – “held to the June lows in the most recent late Q3 move to the downside." Wald also notes that the signal of a market top is when the S&P 500 makes a “higher high, and small caps make a lower high," and we are currently seeing the opposite scenario pla
The headwinds have piled up for the US economy, and today’s producer price index, coming in well above the forecasts, was just the latest blow. As the PPI reminds us, inflation is stubbornly high, and compounding on last year’s elevated numbers. In addition, we’re facing a 1H GDP contraction, a nosedive in consumer confidence, shaky supplies chains, and the Federal Reserve’s rapid shift to hiking interest rates. And all of that may just be the tip of the iceberg. Billionaire investor Ray Dalio s
(Bloomberg) — Treasury Secretary Janet Yellen cited concerns about the potential for a breakdown in trading of US Treasuries, as her department leads an effort to shore up that crucial market.Most Read from BloombergIntel Is Planning Thousands of Job Cuts in Face of PC SlumpHere’s How Weird Things Are Getting in the Housing MarketPutin Says All Infrastructure at Risk After Nord Stream HitAlex Jones Must Pay $965 Million for His Sandy Hook LiesUS Core Inflation Seen Returning to 40-Year High as
Housebuilders were amongst the largest fallers during the morning due to recent signs of slowing house prices.
AMD's preliminary Q3 results contributed to a massive sell-off in the stock, but many believe this reaction was overblown.
The Dow Jones Industrial Average ended a day of choppy trading with a 0.1% drop. The morning's 0.2% uptick faded early, but the index built momentum after the Fed's minutes release at 11 a.m. ET. The Fed's minutes on Wednesday showed that the path to higher interest rates remains intact.
In this article, we shall discuss the top 12 picks in Carl Icahn’s stock portfolio. To skip our detailed analysis of Icahn’s history, his investment strategy, and hedge fund performance, go directly and see Carl Icahn Stock Portfolio: Top 5 Picks. Carl Icahn is an American financier and currently serves as the Chief Executive Officer […]
Stocks were quiet Wednesday, as investors avoided rallying into the CPI inflation report. EV plays Albemarle and Aehr Test Systems dived.
Cannabis stocks have been on fire of late as hopes surrounding marijuana reform in the U.S. have put them back into the spotlight. Tilray is a top cannabis company in Canada, with sales totaling $613.6 million over the trailing 12 months. Although the company is technically still incurring net losses, Tilray is known for being one of the more profitable businesses in the industry, achieving adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) profitability for 14 straight quarters.
U.S. stock-index futures advanced Thursday ahead of the week's big event, the release of September consumer price inflation data.
Don’t assume the worst is over, says investor Larry McDonald. McDonald, founder of The Bear Traps Report and author of “A Colossal Failure of Common Sense,” which described the 2008 failure of Lehman Brothers, expects more turmoil in the bond market, in part, because “there is $50 trillion more in world debt today than there was in 2018.” The bond market dwarfs the stock market — both have fallen this year, although the rise in interest rates has been worse for bond investors because of the inverse relationship between rates (yields) and bond prices.
SQM (SQM) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
(Bloomberg) — Taiwan Semiconductor Manufacturing Co. slashed its 2022 capital spending target by roughly 10%, a dramatic sign of trouble for the technology industry from the world’s most valuable chip company.Most Read from BloombergIntel Is Planning Thousands of Job Cuts in Face of PC SlumpHere’s How Weird Things Are Getting in the Housing MarketPutin Says All Infrastructure at Risk After Nord Stream HitAlex Jones Must Pay $965 Million for His Sandy Hook LiesTSMC said it expects to spend about
Tesla bears have been on a roll over the past two weeks — opening increasingly intense bearish option trades against the EV giant in the face of the stock's continued plunge.
"The travel recovery continues as consumer spend shifts to experiences and demand improves in corporate and international," said CEO Ed Bastian.
Stock futures higher as inflation test looms; CPI data likely mixed, but trending slowly downward; Taiwan semi posts robust earnings, muted outlook; Applied Materials cuts profit forecast on U.S.-China export rules and Delta Air lines earnings in focus amid solid travel demand.